CYTO logo

Altamira Therapeutics (CYTO) Revenue

Annual Revenue

$188.40 K
-$132.00 K-41.20%

December 1, 2023


Summary


Performance

CYTO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYTOprofitabilitymetrics:

CYTO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-41.2%--
3 y3 years---
5 y5 years---

CYTO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-41.2%+169.5%
5 y5-year-41.2%+169.5%
alltimeall time-41.2%+169.5%

Altamira Therapeutics Revenue History

DateAnnualQuarterlyTTM
Dec 2023
$188.40 K(-41.2%)
-
-
DateAnnualQuarterlyTTM
Dec 2022
$320.40 K(+358.4%)
-
-
Dec 2021
$69.90 K
-
-

FAQ

  • What is Altamira Therapeutics annual revenue?
  • What is the all time high annual revenue for Altamira Therapeutics?
  • What is Altamira Therapeutics annual revenue year-on-year change?

What is Altamira Therapeutics annual revenue?

The current annual revenue of CYTO is $188.40 K

What is the all time high annual revenue for Altamira Therapeutics?

Altamira Therapeutics all-time high annual revenue is $320.40 K

What is Altamira Therapeutics annual revenue year-on-year change?

Over the past year, CYTO annual revenue has changed by -$132.00 K (-41.20%)